Headquartered in Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional full-service CRO. With the increasing pace of globalization in drug development, Novotechâ€™s expertise in the vibrant and fast growing Asian region has been instrumental in the success of hundreds of phase I-IV clinical trials from Australia to India. Headquartered in Sydney, with operations in New Zealand, China, Hong Kong, India, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand, Novotechâ€™s service offering has come to be recognized for its quality both by our clients, as well as industry analyst groups.
Offices in South_korea:
Seoul Novotech, 4F, City Airport, 22 Teheran-ro 87-gil, Gangnam-gu, Seoul 06164, Republic of Korea